Icoria, which has changed its focus to biotechnology from crop science, cut its quarterly losses to $3 million in its most recent quarter.

A year ago, Icoria (OTC: ICOR.BB) lost $3.6 million.

Healthcare revenues climbed to $2.5 million, up 11 percent from 2004.

Icoria: www.icoria.com